Page 46 - Demo

Chapter 24460. Martin DM, Roy A, Wells MB. Health gain through health checks: improving access to primary health care for people with intellectual disability. J Intellect Disabil Res. 1997;41:401-8.61. Straetmans J, van Schrojenstein Lantman-de Valk H, Schellevis F, Dinant G. Health problems of people with intellectual disabilities: the impact for general practice. Br J Gen Pract 2007;57(534):64-6.62. Taylor SC, Markar TN. Audit of the quality of general practitioner referral letters to a learning disability service. Int J Dev Disabil. 2002;48(95):101-6.63. Messinger-Rapport BJ, Rapport DJ. Primary care for the developmentally disabled adult. J Gen Intern Med 1997;12(10):629-36.64. Health care in people with intellectual disability; Guidelines for general practitioners. Centre for Developmental Disability Studies. Sidney; 2006. [Available from: https://aci.health.nsw.gov.au/__data/assets/pdf_file/0016/231514/CDDS-Health-care-in-people-with-intellectualdisability.pdf]. 65. Psychotropic drug prescribing for people with intellectual disability, mental health problems and/or behaviours that challenge: practice guidelines. Royal college of psychiatrists; 2016. [Available from: https://www.rcpsych.ac.uk/docs/default-source/members/faculties/intellectual-disability/id-faculty-report-id-09.pdf?sfvrsn=55b66f2c_6]66. Phillips A, Morrison J, Davis RW. General practitioners’ educational needs in intellectual disability health. J Intellect Disabil Res. 2004;48:142-9.67. Bakker-van Gijssel EJ, Leusink GL. Psychotropic drug prescription to people with intellectual disability in GP practices. Ned Tijdschr Geneeskd. 2015;159:A9754.68. Davis R, Mohr C. The assessment and treatment of behavioural problems. Aust Fam Physician. 2004;33(8):609-13.69. Green L, McNeil K, Korossy M, et al. HELP for behaviours that challenge in adults with intellectual and developmental disabilities. Can Fam Physician. 2018;64:S23-s31.70. Munden AC, Perry DW. Symptoms of depression in people with learning disabilities. J Learn Disabil. 2002;6(1):13-22.71. Prater CD, Zylstra RG. Medical care of adults with mental retardation. Am Fam Physician. 2006; 6(73):2175-83.72. Woods R. Behavioural concerns-assessment and management of people with intellectual disability. Aust Fam Physician. 2011;40(4):198-200.73. Tracy J, Davis R, Macgibbon P, Graham M. Medication review guide for GPs. A guide for GPs on the use of psychoactive medications for adults with intellectual disability who present with behaviours of concern. Centre for Developmental Disability Health Victoria; 2015. [Available from: https://www.cddh.monashhealth.org/wp-content/uploads/2016/11/2015-medicationreview-guide-for-gps.pdf]74. Doan TN, Lennox NG, Taylor-Gomez M, Ware RS. Medication use among Australian adults with intellectual disability in primary healthcare settings: a cross-sectional study. J Intellect Dev Disabil. 2013;38(2):177-81.75. Glover G, Williams R. Prescribing of psychotropic drugs to people with learning disabilities and/or autism by general practitioners in England. Public Health England; 2015. [Available from: https://clok.uclan.ac.uk/17970/1/Psychotropic medication and people with learning disabilities or autism.pdf]76. Adams D. Pharmacists’ role in optimising the use of medicines in those with learning disabilities. Pharm J. 2016;8(3).77. Glover G, Williams R, Branford D, et al. Psychotropic prescribing by general practitioners for people with intellectual and developmental disabilities in England. J Intellect Disabil Res. 2016;60(7-8):672.78. Molyneaux P, Emerson E, Caine A. Prescription of psychotropic medication to people with intellectual disabilities in primary health-care settings. J Appl Res Intellect Disabil. 1999;12(1):46-57.79. Sheehan R, Horsfall L, Walters K, et al. Psychotropic prescribing for people with intellectual disability in UK primary care. J Intellect Disabil Res. 2015;1:118-9.Katrien Pouls sHL.indd 44 24-06-2024 16:26